Elevance Health Inc. Stock Underperforms Monday When Compared To Competitors

Dow Jones

2025.12.01 21:41

I'm PortAI, I can summarize articles.

Elevance Health Inc. shares fell 2.54% to $329.68 on Monday, underperforming compared to competitors like UnitedHealth Group, Cigna Group, and Humana Inc. The stock is 28.14% below its 52-week high of $458.75. Trading volume was 1.4 million, below the 50-day average of 1.7 million. The S&P 500 and Dow Jones also declined.

This article was automatically generated by MarketWatch using technology from Automated Insights. Shares of Elevance Health Inc. (ELV) slid 2.54% to $329.68 Monday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index falling 0.53% to 6,812.63 and Dow Jones Industrial Average falling 0.90% to 47,289.33. This was the stock's second consecutive day of losses. Elevance Health Inc. closed 28.14% below its 52-week high of $458.75, which the company reached on April 8th. The stock underperformed when compared to some of its competitors Monday, as UnitedHealth Group Inc. (UNH) fell 1.99% to $323.21, Cigna Group (CI) fell 1.34% to $273.57, and Humana Inc. (HUM) fell 1.44% to $242.23. Trading volume (1.4 M) remained 359,997 below its 50-day average volume of 1.7 M. Data source: Dow Jones Market Data, FactSet. Data compiled December 1, 2025. This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal. (END) Dow Jones Newswires 12-01-25 1641ET